Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene therapy with covalently closed-end AAV vector for spinal muscular atrophy

14 Jun 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Muscle Physiology and Disorders
Share to Neurogenetic and Muscular Disorders Research

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 40518668
DOI: 10.1016/j.ymthe.2025.06.028

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene therapy with covalently closed-end AAV vector for spinal muscular atrophyPMID 40518668Read ↗

AAV9 Vector: a Novel modality in gene therapy for spinal muscular atrophySemantic proximity Read ↗

The progress of AAV-mediated gene therapy in neuromuscular disordersSemantic proximity Read ↗

Viral vector-mediated gene therapiesSemantic proximity Read ↗

Meeting Report: 2022 Muscular Dystrophy Association Summit on ‘Safety and Challenges in Gene Transfer Therapy’Semantic proximity Read ↗

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular DystrophySemantic proximity Read ↗

Prospects for the gene therapy of spinal muscular atrophySemantic proximity Read ↗

A Review of Gene Therapy Delivery Systems for Intervertebral Disc DegenerationSemantic proximity Read ↗

Muscular Gene Transfer Using Nonviral VectorsSemantic proximity Read ↗

Muscle‐directed gene therapy for hemophilia B with more efficient and less immunogenic AAV vectorsSemantic proximity Read ↗

Gene Therapy for Intervertebral Disk DegenerationSemantic proximity Read ↗

Challenges for gene therapy for muscular dystrophy.Semantic proximity Read ↗

AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trialsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.